US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 24.920
  • +0.640+2.64%
Close Dec 20 16:00 ET
  • 25.010
  • +0.090+0.36%
Post 20:01 ET
11.07BMarket Cap9.81P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
Cystic fibrosis franchise205.7M36.43%
Other products133.34M23.61%
Evrysdi56.75M10.05%
Trelegy37.59M6.66%
Tremfya37.29M6.60%
IMBRUVICA32.14M5.69%
Other royalty income and revenues31.52M5.58%
TYSABRI30.36M5.38%
View all
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.35B100.00%
Heat List
US
Overall
Symbol
Price
% Chg

No Data